You just read:

Actinium Pharmaceuticals Announces Iomab-ACT Program Gene Therapy Collaboration with UC Davis in Ongoing Clinical Trial for Patients with HIV-Related Lymphoma

News provided by

Actinium Pharmaceuticals, Inc.

Jan 13, 2020, 07:03 ET